Uniscan Diagnostic Profile
Key Indicators
- Authorised Capital ₹ 0.18 M
as on 27-12-2024
- Paid Up Capital ₹ 0.18 M
as on 27-12-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.16 Cr
as on 27-12-2024
- Revenue %
(FY 2020)
- Profit -100.85%
(FY 2020)
- Ebitda 92.75%
(FY 2020)
- Net Worth 16.87%
(FY 2020)
- Total Assets -56.93%
(FY 2020)
About Uniscan Diagnostic
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.18 M and a paid-up capital of Rs 0.18 M.
The company currently has active open charges totaling ₹8.16 Cr.
Shirish Gandhi, Ajit Kurlekar, Mohit Patil, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85110PN2005PTC020735
- Company No.
020735
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Uniscan Diagnostic?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parag Sancheti  | Director | 13-May-2005 | Current |
| Shirish Gandhi | Director | 25-Jul-2005 | Current |
| Ajit Kurlekar | Director | 25-Jul-2005 | Current |
| Mohit Patil | Director | 25-Jul-2005 | Current |
| Vikramsingh Chohan | Director | 13-May-2005 | Current |
| Mahendra Gulati | Director | 13-May-2005 | Current |
Financial Performance of Uniscan Diagnostic.
Uniscan Diagnostic Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 100.85% decrease in profit. The company's net worth Soared by an impressive increase of 16.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uniscan Diagnostic?
In 2020, Uniscan Diagnostic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹81.60 M
₹0
Charges Breakdown by Lending Institutions
- The Saraswat Co-Operative Bank Limited : 5.91 Cr
- The Saraswat Co Op Bank Ltd : 2.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Sep 2014 | The Saraswat Co-Operative Bank Limited | ₹1.00 Cr | Open |
| 20 Jun 2011 | The Saraswat Co-Operative Bank Limited | ₹3.37 Cr | Open |
| 28 Oct 2009 | The Saraswat Co-Operative Bank Limited | ₹1.54 Cr | Open |
| 10 Nov 2005 | The Saraswat Co Op Bank Ltd | ₹2.25 Cr | Open |
How Many Employees Work at Uniscan Diagnostic?
Unlock and access historical data on people associated with Uniscan Diagnostic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uniscan Diagnostic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uniscan Diagnostic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
